Physician profile
Maria Bernabe
NPI 1851619423
$513.12
in general payments reported to CMS, 2019-2025
11 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.41 · 2020: $16.49 · 2021: $31.43 · 2023: $83.34 · 2024: $202 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.25 | 2023-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $83.44 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $69.00 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.01 | 2025 | Caplyta |
| Scpharmaceuticals INC. | $34.40 | 2024 | |
| Neurocrine Biosciences, INC. | $33.87 | 2020-2025 | |
| Hologic Sales and Service, LLC | $29.84 | 2019 | |
| Axsome Therapeutics, INC. | $27.04 | 2024 | Auvelity |
| Abbvie INC. | $19.28 | 2024 | |
| Pfizer INC. | $13.50 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $13.49 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Bernabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.